These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1860683)

  • 1. The metabolic bone disease of primary sclerosing cholangitis.
    Hay JE; Lindor KD; Wiesner RH; Dickson ER; Krom RA; LaRusso NF
    Hepatology; 1991 Aug; 14(2):257-61. PubMed ID: 1860683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression.
    Angulo P; Therneau TM; Jorgensen A; DeSotel CK; Egan KS; Dickson ER; Hay JE; Lindor KD
    J Hepatol; 1998 Nov; 29(5):729-35. PubMed ID: 9833910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of liver disease does not predict osteopenia or low bone mineral density in primary sclerosing cholangitis.
    Campbell MS; Lichtenstein GR; Rhim AD; Pazianas M; Faust T
    Liver Int; 2005 Apr; 25(2):311-6. PubMed ID: 15780055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis.
    Hay JE; Malinchoc M; Dickson ER
    J Hepatol; 2001 Feb; 34(2):292-8. PubMed ID: 11281559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry.
    Guichelaar MM; Malinchoc M; Sibonga J; Clarke BL; Hay JE
    Hepatology; 2002 Oct; 36(4 Pt 1):895-903. PubMed ID: 12297836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone disorders in cholestatic liver diseases.
    Isaia G; Di Stefano M; Roggia C; Ardissone P; Rosina F
    Forum (Genova); 1998; 8(1):28-38. PubMed ID: 9514992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced spinal and femoral bone mass and deranged bone mineral metabolism in chronic alcoholics.
    Peris P; Parés A; Guañabens N; Pons F; Martínez de Osaba MJ; Caballería J; Rodés J; Muñoz-Gómez J
    Alcohol Alcohol; 1992 Nov; 27(6):619-25. PubMed ID: 1292434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
    Lindström L; Lapidus A; Ost A; Bergquist A
    Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
    Trottier J; Białek A; Caron P; Straka RJ; Heathcote J; Milkiewicz P; Barbier O
    Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral affection in asymptomatic adult patients with celiac disease.
    Mazure R; Vazquez H; Gonzalez D; Mautalen C; Pedreira S; Boerr L; Bai JC
    Am J Gastroenterol; 1994 Dec; 89(12):2130-4. PubMed ID: 7977227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heritability of bone mineral density.
    François S; Benmalek A; Guaydier-Souquières G; Sabatier JP; Marcelli C
    Rev Rhum Engl Ed; 1999 Mar; 66(3):146-51. PubMed ID: 10327493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement.
    Mäkinen TJ; Alm JJ; Laine H; Svedström E; Aro HT
    Bone; 2007 Apr; 40(4):1041-7. PubMed ID: 17239668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis.
    Frost ML; Fogelman I; Blake GM; Marsden PK; Cook G
    J Bone Miner Res; 2004 Nov; 19(11):1797-804. PubMed ID: 15476579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone involvement in patients with chronic cholestasis.
    Le Gars L
    Joint Bone Spine; 2002 Jun; 69(4):373-8. PubMed ID: 12184433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipids in primary sclerosing cholangitis.
    Sinakos E; Abbas G; Jorgensen RA; Lindor KD
    Dig Liver Dis; 2012 Jan; 44(1):44-8. PubMed ID: 21890438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary tract calculi in primary sclerosing cholangitis.
    Kaw M; Silverman WB; Rabinovitz M; Schade RR
    Am J Gastroenterol; 1995 Jan; 90(1):72-5. PubMed ID: 7801953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
    Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic failure after injury - a common pathogenesis with sclerosing cholangitis?
    Zilkens C; Friese J; Köller M; Muhr G; Schinkel C
    Eur J Med Res; 2008 Jul; 13(7):309-13. PubMed ID: 18700186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.